Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
Fermenta Biotech Lists Shares on NSE, Maintains BSE Listing

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

Fermenta Biotech Lists Shares on NSE, Maintains BSE Listing

Analysed 4 Aug 2026·2 sources analysed·Mumbai, India·Business
Fermenta Biotech Lists Shares on NSE, Maintains BSE ListingPreviousNext

Fermenta Biotech successfully listed its 2.94 crore equity shares on the National Stock Exchange of India (NSE) on August 4, 2026, under the symbol FERMENTA, while continuing its listing on the Bombay Stock Exchange (BSE). The dual listing aims to enhance investor access, market visibility, and price discovery. Founded in 1951, Fermenta is a leading global manufacturer of Vitamin D3 and other specialized pharmaceutical and nutritional products, serving over 60 countries.

Sentiment
62%
TBN's observations

First-hand measurement across 2 sources

We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (62/100). Lens Score 38/100.

Outlets measured: businessstandard, freepressjournal. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 4 Aug 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Positive (62/100)

Sentiment was consistent across outlets (50–75/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

freepressjournal broke this story on 4 Aug, 11:58 am. Other outlets followed.

4 Aug, 11:58 am2 sources · 3 h4 Aug, 03:12 pm
  1. 1
AI analysis by the TBN Bias Engine · beat methodology byMrunal Wange· Business & Economy Editor· editorial standards byOjas Kale
← Previous
India's Pharma Industry Expected to Miss 2030 Sales Target Amid Export Challenges
Next →
Guidance on Reverse Mortgages and Home Loans for Under-Construction Properties
freepressjournal4 Aug, 11:58 am
Fermenta Biotech Lists On NSE, Dual-Exchange Presence Set To Widen Investor Access
  • 2
    businessstandard4 Aug, 03:12 pm
    Shares of Fermenta Biotech list on NSE
  • Who's involved

    Institutions and figures named across source coverage.

    Corporate
    Bombay Stock ExchangeFermenta BiotechNational Stock Exchange of India

    Story context

    Category
    Business
    Location
    Mumbai, India
    Sources analysed
    2
    Last analysed
    4 Aug 2026
    Key entities
    National Stock Exchange of IndiaCommon stockIndian rupeeBombay Stock ExchangeInternational Securities Identification NumberFace valueKrishnagiri districtGulf OilLubricantData centerJoint ventureInformation technology